Prosecution Insights
Prosecution Insights
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 3 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LE, AUSTIN Q | 1 | 48.8% | +33.7% |
| MIKNIS, ZACHARY J | 1 | 68.3% | +32.5% |
| KINSEY WHITE, NICOLE ERIN | 1 | 58.0% | +16.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18058169 | VIRAL NUCLEIC ACID MOLECULES, AND COMPOSITIONS AND METHODS OF USE THEREOF | KINSEY WHITE, NICOLE ERIN | 23d overdue |
| 18472228 | SELF-DILUTING MICROFLUIDIC DEVICE FOR RAPID ANTIMICROBIAL SUSCEPTIBILITY TESTS | LE, AUSTIN Q | 19d |
| 18350402 | COMPOSITIONS OF CASPASE INHIBITORS AND METHODS OF USE THEREOF | MIKNIS, ZACHARY J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18058169 | VIRAL NUCLEIC ACID MOLECULES, AND COMPOSITIONS AND METHODS OF USE THEREOF | KINSEY WHITE, NICOLE ERIN | 23d overdue |
| 18472228 | SELF-DILUTING MICROFLUIDIC DEVICE FOR RAPID ANTIMICROBIAL SUSCEPTIBILITY TESTS | LE, AUSTIN Q | 19d |
| 18350402 | COMPOSITIONS OF CASPASE INHIBITORS AND METHODS OF USE THEREOF | MIKNIS, ZACHARY J | — |
| Art Unit | Apps |
|---|---|
| 1796 | 1 |
| 1658 | 1 |
| 1672 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18472228 | SELF-DILUTING MICROFLUIDIC DEVICE FOR RAPID ANTIMICROBIAL SUSCEPTIBILITY TESTS | LE, AUSTIN Q | 1796 | §102§103§112 | Non-Final OA | 19d | Pending | Sep 22, 2023 |
| 18350402 | COMPOSITIONS OF CASPASE INHIBITORS AND METHODS OF USE THEREOF | MIKNIS, ZACHARY J | 1658 | §102§112 | Non-Final OA | — | Pending | Jul 11, 2023 |
| 18058169 | VIRAL NUCLEIC ACID MOLECULES, AND COMPOSITIONS AND METHODS OF USE THEREOF | KINSEY WHITE, NICOLE ERIN | 1672 | §102§103§112 | Non-Final OA | 23d overdue | Pending | Nov 22, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial